Isabel Silva
Overview
Explore the profile of Isabel Silva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
Moura T, Caramelo O, Silva I, Silva S, Goncalo M, Portilha M, et al.
Biomolecules
. 2025 Jan;
15(1).
PMID: 39858472
Background: Breast cancer is a heterogeneous malignant disease with a varying prognosis and is classified into four molecular subtypes. It remains one of the most prevalent cancers globally, with the...
4.
Silva I, Rodrigues E, Tacao M, Henriques I
Chemosphere
. 2024 Nov;
368:143800.
PMID: 39581438
Microplastics (MPs) are found even in remote and low-pollution freshwater ecosystems. However, the microbial communities associated with MPs in these environments remain poorly understood. We characterized the plastisphere in a...
5.
Daher R, Silva I, Khattri S
Arch Dermatol Res
. 2024 Nov;
316(10):749.
PMID: 39503795
No abstract available.
6.
Silva D, Laranjeira P, Silva A, Silva I, Kaminska M, Mydel P, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274511
: Immune cells from rheumatoid arthritis (RA) patients display a reduced in vitro response to (), which may have functional immune consequences. The aim of this study was to characterize,...
7.
Gupta R, Silva I, Herzog I, Firouzbakht P, Weisberger J, Vosbikian M, et al.
J Hand Surg Glob Online
. 2024 Aug;
6(4):551-557.
PMID: 39166189
Purpose: Due to the Coronavirus Disease-19 pandemic, the fellowship application process has transitioned from in-person interviews to virtual interviews. Although several studies have assessed the impact of Coronavirus Disease-19 on...
8.
Borges-Carneiro F, Torre Souto M, Silva I, Moreira P, Ferraz de Oliveira P, Lopes D, et al.
Acta Med Port
. 2024 Jul;
37(9):585-588.
PMID: 39082316
No abstract available.
9.
Varela R, Gonzalez-Ortiz F, Dias A, Knuth N, Fonte J, Pinto B, et al.
Stroke
. 2024 Jul;
55(9):2353-2358.
PMID: 39051090
Background: Large vessel occlusion acute ischemic stroke prognosis improved following the 2015 endovascular therapy (EVT) trials. Blood-based biomarkers may improve outcome prediction. We aimed to assess plasma brain-derived tau (BD-Tau)...
10.
DAmico F, Massimino L, Palmieri G, Dal Buono A, Gabbiadini R, Caron B, et al.
Eur J Clin Invest
. 2024 Jul;
54(11):e14283.
PMID: 38979834
Background And Aims: Subcutaneous (SC) formulations of infliximab (IFX) and vedolizumab (VDZ) are approved for the treatment of inflammatory bowel diseases (IBDs). Our aim was to evaluate the effectiveness of...